Compound One: New Cancer Treatment
Dayton News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Researchers at the University of Texas at Austin and MD Anderson Cancer Center have developed an experimental drug, Compound One, that tricks cancer cells into signaling like infected cells. This triggers the immune system to attack the cancer, and the treatments effects can last even after the drug is no longer present. The team is excited about using less chemo for better results, with fewer side effects and stronger outcomes. They plan to test popular chemo drugs to see if they can also trigger this immune response, potentially simplifying treatments and making them more effective. This promising research, backed by federal grants and university funding, offers a new approach to fighting cancer by combining smart drugs with natural immunity.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/9e8ee99ca28ef0ca